Article
Revertant mutants G550E and 4RK rescue cystic fibrosis mutants in the first nucleotide-binding domain of CFTR by different mechanisms.
Proceedings of the National Academy of Sciences of the United States of America - 21 Nov 2006
Roxo-Rosa Mónica, Xu Zhe, Schmidt André, Neto Mário, Cai Zhiwei, Soares Cláudio M, Sheppard David N, Amaral Margarida D
Abstract excerpt
The revertant mutations G550E and 4RK [the simultaneous mutation of four arginine-framed tripeptides (AFTs): R29K, R516K, R555K, and R766K] rescue the cell surface expression and function of F508del-cystic fibrosis (CF) transmembrane conductance regulator (-CFTR), the most common CF mutation. Here, we investigate their mechanism of action by using biochemical and functional assays to examine their effects on...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
